Phase II trial of AV-GBM-1 (autologous dendritic cells loaded with autologous tumor associated antigens) as an adjunctive therapy following primary surgery plus concurrent chemoradiation in patients with newly diagnosed glioblastoma

Investigator(s):
Daniela Bota, M.D., Ph.D.
Organization: 
UCI
NCT Number: 
Disease Name: 
Glioblastoma
Disease Category: 
Trial Phases: 
Phase 2
Trial Status: 
Recruiting
Trial Contact: 

Active trials at UCI: http://clinic.stemcell.uci.edu/search-clinical-trials.asp

Contact for all open studies at UCI:
(949) 824-3990
stemcell@uci.edu